Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Obefazimod

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abivax to Present 22 Obefazimod Abstracts in IBD at ECCO 2026
    Abivax to Present 22 Obefazimod Abstracts in IBD at ECCO 2026

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3207315/0/en/Abivax-Announces-Acceptance-of-22-Abstracts-Evaluating-Obefazimod-in-Inflammatory-Bowel-Disease-at-ECCO-2026-Featuring-an-Oral-Presentation-on-Preclinical-Anti-Fibrotic-Findings.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    Abivax Ph3 Obefazimod Data Show QoL Gains in Ulcerative Colitis
    Abivax Ph3 Obefazimod Data Show QoL Gains in Ulcerative Colitis

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179780/0/en/Abivax-Announces-Patient-Reported-Outcomes-Data-from-the-Phase-3-ABTECT-Induction-Trials-of-Obefazimod-Demonstrating-Significant-Improvements-in-Quality-of-Life-for-Patients-with-M.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Abivax Presents 8-Week ABTECT Data From Late-Breaking Session
    Abivax Presents 8-Week ABTECT Data From Late-Breaking Session

    06 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/06/3161446/0/en/Abivax-Announces-Late-Breaking-Presentation-of-8-Week-ABTECT-Induction-Trial-Results-in-Participants-With-and-Without-Prior-Inadequate-Response-to-Advanced-Therapies.html

    GLOBENEWSWIRE
    06 Oct 2025
    Share Share
    Abivax Presents 8-Week ABTECT Trial Results With Safety Update
    Abivax Presents 8-Week ABTECT Trial Results With Safety Update

    05 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/05/3161328/0/en/Abivax-Announces-Late-Breaking-Presentation-of-8-Week-ABTECT-Trial-Results-with-Updated-Safety-Data.html

    GLOBENEWSWIRE
    05 Oct 2025
    Share Share
    Abivax To Present Late-Breaking Abtect Phase 3 Data At 2025 UEG
    Abivax To Present Late-Breaking Abtect Phase 3 Data At 2025 UEG

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3158107/0/en/Abivax-Announces-Acceptance-of-Additional-Late-Breaking-Abstract-from-the-ABTECT-Phase-3-Induction-Trials-to-be-Presented-at-2025-United-European-Gastroenterology-UEG-Meeting.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share
    Abivax Presents Obefazimod ABTECT Ph 3 Trials at 2025 UEG Meeting
    Abivax Presents Obefazimod ABTECT Ph 3 Trials at 2025 UEG Meeting

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3155082/0/en/Abivax-Announces-Presentation-of-Late-Breaking-Abstract-for-Obefazimod-from-the-ABTECT-Phase-3-Induction-Trials-at-2025-United-European-Gastroenterology-UEG-Meeting.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.